InvestorsHub Logo
Followers 4
Posts 157
Boards Moderated 0
Alias Born 05/04/2012

Re: None

Wednesday, 11/26/2014 11:26:40 PM

Wednesday, November 26, 2014 11:26:40 PM

Post# of 402943

BK why would Cellceutix file a patient with Rutgers for one of their compounds?

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,895,561.PN.&OS=PN/8,895,561&RS=PN/8,895,561


I guess Rutgers is the New Jersey university they were signing a material transfer agreement in this PR.

BEVERLY, MA–(Marketwired – May 27, 2014) – Cellceutix Corporation (OTCQB: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, is pleased to report that the Company has signed material transfer agreements for compounds in its defensin mimetics portfolio with major university laboratories located in New York and New Jersey. These laboratories do significant government work and have expertise in anti-infective, anti-fungal and bio-defense applications. Cellceutix will be shipping the compounds to the university laboratories in the coming weeks. It is hoped that these collaborations will result in government assistance in developing the Company’s novel compounds for a broad spectrum of indications.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News